154 related articles for article (PubMed ID: 37446604)
21. In silico carborane docking to proteins and potential drug targets.
Calvaresi M; Zerbetto F
J Chem Inf Model; 2011 Aug; 51(8):1882-96. PubMed ID: 21774557
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy.
Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
J Med Chem; 2005 Feb; 48(4):1188-98. PubMed ID: 15715485
[TBL] [Abstract][Full Text] [Related]
23. Practical synthesis of 1,12-difunctionalized o-carborane for the investigation of polar liquid crystals.
Jankowiak A; Kaszyński P
Inorg Chem; 2014 Aug; 53(16):8762-9. PubMed ID: 25089762
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and characterization of nido-carborane-cobalamin conjugates.
Hogenkamp HP; Collins DA; Live D; Benson LM; Naylor S
Nucl Med Biol; 2000 Jan; 27(1):89-92. PubMed ID: 10755651
[TBL] [Abstract][Full Text] [Related]
25. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
26. Towards carborane-functionalised structures for the treatment of brain cancer.
Calabrese G; Daou A; Barbu E; Tsibouklis J
Drug Discov Today; 2018 Jan; 23(1):63-75. PubMed ID: 28886331
[TBL] [Abstract][Full Text] [Related]
27. Photophysical Properties of Spirobifluorene-Based
Kim S; So H; Lee JH; Hwang H; Kwon H; Park MH; Lee KM
Molecules; 2019 Nov; 24(22):. PubMed ID: 31731632
[TBL] [Abstract][Full Text] [Related]
28. [18F]fluorination of o-carborane via nucleophilic substitution: towards a versatile platform for the preparation of 18F-labelled BNCT drug candidates.
Gona KB; Gómez-Vallejo V; Padro D; Llop J
Chem Commun (Camb); 2013 Dec; 49(98):11491-3. PubMed ID: 24175318
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of monosubstituted functional derivatives of carboranes from 1-mercapto-ortho-carborane: 1-HOOC(CH(2))(n)S-1,2-C(2)B(10)H(11) and [7-HOOC(CH(2))(n)S-7,8-C(2)B(9)H(11)](-) (n = 1-4).
Stogniy MY; Sivaev IB; Petrovskii PV; Bregadze VI
Dalton Trans; 2010 Feb; 39(7):1817-22. PubMed ID: 20449427
[TBL] [Abstract][Full Text] [Related]
30. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy.
Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Lerchen HG; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
J Org Chem; 2020 Feb; 85(3):1446-1457. PubMed ID: 31813224
[TBL] [Abstract][Full Text] [Related]
31. Liposome formulations of o-carborane for the boron neutron capture therapy of cancer.
Olusanya TOB; Calabrese G; Fatouros DG; Tsibouklis J; Smith JR
Biophys Chem; 2019 Apr; 247():25-33. PubMed ID: 30797076
[TBL] [Abstract][Full Text] [Related]
32. Tumor-targeting hyaluronic acid/fluorescent carborane complex for boron neutron capture therapy.
Yamana K; Kawasaki R; Sanada Y; Tabata A; Bando K; Yoshikawa K; Azuma H; Sakurai Y; Masunaga SI; Suzuki M; Sugikawa K; Nagasaki T; Ikeda A
Biochem Biophys Res Commun; 2021 Jun; 559():210-216. PubMed ID: 33957482
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of Bis(Carboranyl)amides 1,1'-μ-(CH
Asawa Y; Arsent'eva AV; Anufriev SA; Anisimov AA; Suponitsky KY; Filippov OA; Nakamura H; Sivaev IB
Molecules; 2021 Mar; 26(5):. PubMed ID: 33801248
[TBL] [Abstract][Full Text] [Related]
34. Ru(ii) and Ir(iii) phenanthroline-based photosensitisers bearing o-carborane: PDT agents with boron carriers for potential BNCT.
Conway-Kenny R; Ferrer-Ugalde A; Careta O; Cui X; Zhao J; Nogués C; Núñez R; Cabrera-González J; Draper SM
Biomater Sci; 2021 Aug; 9(16):5691-5702. PubMed ID: 34264257
[TBL] [Abstract][Full Text] [Related]
35. Impact of deboronation on the electronic characteristics of closo-o-carborane: intriguing photophysical changes in triazole-appended carboranyl luminophores.
Kim M; Im S; Ryu CH; Lee SH; Hong JH; Lee KM
Dalton Trans; 2021 Mar; 50(9):3207-3215. PubMed ID: 33576753
[TBL] [Abstract][Full Text] [Related]
36. Tuning the Cell Uptake and Subcellular Distribution in BODIPY-Carboranyl Dyads: An Experimental and Theoretical Study.
Labra-Vázquez P; Flores-Cruz R; Galindo-Hernández A; Cabrera-González J; Guzmán-Cedillo C; Jiménez-Sánchez A; Lacroix PG; Santillan R; Farfán N; Núñez R
Chemistry; 2020 Dec; 26(69):16530-16540. PubMed ID: 32608048
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, NMR, and X-ray crystallographic analysis of C-hydrazino-C-carboxycarboranes: versatile ligands for the preparation of BNCT and BNCS agents and (99m)Tc radiopharmaceuticals.
Valliant JF; Sogbein OO; Morel P; Schaffer P; Guenther KJ; Bain AD
Inorg Chem; 2002 May; 41(10):2731-7. PubMed ID: 12005497
[TBL] [Abstract][Full Text] [Related]
38. A convenient method for the computer-aided molecular design of carborane containing compounds.
Johnsamuel J; Byun Y; Jones TP; Endo Y; Tjarks W
Bioorg Med Chem Lett; 2003 Oct; 13(19):3213-6. PubMed ID: 12951095
[TBL] [Abstract][Full Text] [Related]
39. Boronated phosphonium salts containing arylboronic acid, closo-carborane, or nido-carborane: synthesis, X-ray diffraction, in vitro cytotoxicity, and cellular uptake.
Morrison DE; Issa F; Bhadbhade M; Groebler L; Witting PK; Kassiou M; Rutledge PJ; Rendina LM
J Biol Inorg Chem; 2010 Nov; 15(8):1305-18. PubMed ID: 20694490
[TBL] [Abstract][Full Text] [Related]
40. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
